In rare move, Colombia issues compulsory license for HIV medicine in effort to expand access

The Colombian government on Wednesday issued a compulsory license for a commonly used drug to treat HIV, the first time the government there has stepped in to manufacture a drug without the drugmaker’s permission.

The compulsory license was issued for dolutegravir, which is manufactured by ViiV Healthcare, an HIV-focused drug company operated by GSK. The license gives Colombia’s ministry of health the authority to manufacture the drug under a system established by a World Trade Organization agreement.

Preview

来源: EndPoints

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP

LOG IN

BECOME A PREMIUM SUBSCRIBER

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。